| Common muscle synergies for balance and walking SA Chvatal, LH Ting Frontiers in computational neuroscience 7, 48, 2013 | 287 | 2013 |
| Comprehensive translational assessment of human-induced pluripotent stem cell derived cardiomyocytes for evaluating drug-induced arrhythmias K Blinova, J Stohlman, J Vicente, D Chan, L Johannesen, ... Toxicological Sciences 155 (1), 234-247, 2017 | 226 | 2017 |
| Voluntary and reactive recruitment of locomotor muscle synergies during perturbed walking SA Chvatal, LH Ting Journal of Neuroscience 32 (35), 12237-12250, 2012 | 205 | 2012 |
| Common muscle synergies for control of center of mass and force in nonstepping and stepping postural behaviors SA Chvatal, G Torres-Oviedo, SA Safavynia, LH Ting Journal of neurophysiology 106 (2), 999-1015, 2011 | 189 | 2011 |
| Spatial distribution and acute anti-inflammatory effects of Methylprednisolone after sustained local delivery to the contused spinal cord SA Chvatal, YT Kim, AM Bratt-Leal, H Lee, RV Bellamkonda Biomaterials 29 (12), 1967-1975, 2008 | 168 | 2008 |
| Decomposing muscle activity in motor tasks LH Ting, SA Chvatal Motor control: theories, experiments, and applications, 102-138, 2010 | 148 | 2010 |
| Neuromuscular constraints on muscle coordination during overground walking in persons with chronic incomplete spinal cord injury HB Hayes, SA Chvatal, MA French, LH Ting, RD Trumbower Clinical Neurophysiology 125 (10), 2024-2035, 2014 | 101 | 2014 |
| Review and perspective: neuromechanical considerations for predicting muscle activation patterns for movement LH Ting, SA Chvatal, SA Safavynia, J Lucas McKay International journal for numerical methods in biomedical engineering 28 (10 …, 2012 | 89 | 2012 |
| Novel method for action potential measurements from intact cardiac monolayers with multiwell microelectrode array technology HB Hayes, AM Nicolini, CA Arrowood, SA Chvatal, DW Wolfson, HC Cho, ... Scientific reports 9 (1), 11893, 2019 | 59 | 2019 |
| Absence of postural muscle synergies for balance after spinal cord transection SA Chvatal, JM Macpherson, G Torres-Oviedo, LH Ting Journal of neurophysiology 110 (6), 1301-1310, 2013 | 47 | 2013 |
| Inhibitors of VPS34 and fatty-acid metabolism suppress SARS-CoV-2 replication CG Williams, AS Jureka, JA Silvas, AM Nicolini, SA Chvatal, ... Cell Reports 36 (5), 2021 | 45 | 2021 |
| Inhibitors of VPS34 and lipid metabolism suppress SARS-CoV-2 replication JA Silvas, AS Jureka, AM Nicolini, SA Chvatal, CF Basler Biorxiv, 2020 | 29 | 2020 |
| Cross-site reliability in a cardiac safety assay using multiwell microelectrode array (MEA) technology: preliminary results from the CiPA Pilot Study DC Millard, SA Chvatal, JD Ross | 2 | 2015 |
| Kinetics and potency of T cell and CAR-T cell mediated cytolysis of glioma stem cells HB Hayes, MT Logun, SA Chvatal, K Mueller, N Piscopo, A Das, K Saha, ... Cancer Research 81 (13_Supplement), 1552-1552, 2021 | 1 | 2021 |
| Modified citrus pectin slows migration of triple negative breast cancer cells in an impedance-based scratch assay L Zhu, SA Chvatal, HB Hayes, DC Millard, CT Gomillion Cancer Research 80 (16_Supplement), 4918-4918, 2020 | 1 | 2020 |
| 1271 Development of a functional cardiotoxicity assay for evaluating the safety of cell therapies B Streeter, SH Bhuiyan, G Huang, D Sullivan, A Passaro, S Chvatal, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| Label-free in vitro assays predict the potency of anti-disialoganglioside chimeric antigen receptor T-cell products M Logun, MB Colonna, KP Mueller, D Ventarapragada, R Rodier, ... Cytotherapy 25 (6), 670-682, 2023 | | 2023 |
| Development of a liquid tumor potency assay for evaluation of immune cell-mediated cytotoxicity in vitro D Califano, B Streeter, D Sullivan, A Passaro, S Chvatal, D Millard The Journal of Immunology 210 (1_Supplement), 246.04-246.04, 2023 | | 2023 |
| Development of a repeated challenge potency assay for evaluation of immune cell-mediated cytotoxicity in vitro D Sullivan, S Chvatal, D Millard Cancer Research 83 (7_Supplement), 906-906, 2023 | | 2023 |
| GD2 CAR-T cells engineered using retroviral transduction or CRISPR editing exhibit strong cytolytic potency against glioma stem cells SA Chvatal, MT Logun, DD Sullivan, HB Hayes, D Millard, MP Katie, ... Cancer Research 82 (12_Supplement), 2817-2817, 2022 | | 2022 |
